Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial

Fig. 1

Disposition of trial patients. 1Placebo (PBO), 2Full analysis set, 3One patient with extreme outlier TSS baseline scores was excluded from some exploratory analyses, 4Virus positive patients were those with a positive qualitative test at baseline and/or a detectable quantitative (quantifiable or non-quantifiable) result on a quantitative test at baseline, 5Defined as a detectable quantitative (quantifiable or non-quantifiable) result on panentorhino/Ge/08 assay, 6Quantifiable result on panenterhino/Ge/08 assay

Back to article page